Chemed Analyst Ratings
Chemed Analyst Ratings
| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 10/30/2023 | 7.65% | RBC Capital | $576 → $604 | Maintains | Outperform |
| 07/31/2023 | 2.66% | RBC Capital | $610 → $576 | Maintains | Outperform |
| 07/27/2023 | 5.15% | Oppenheimer | $610 → $590 | Maintains | Outperform |
| 05/01/2023 | 8.72% | RBC Capital | $587 → $610 | Maintains | Outperform |
| 04/28/2023 | 8.72% | Oppenheimer | $580 → $610 | Maintains | Outperform |
| 02/27/2023 | 4.62% | RBC Capital | $545 → $587 | Maintains | Outperform |
| 11/03/2022 | -2.87% | RBC Capital | $541 → $545 | Maintains | Outperform |
| 08/01/2022 | -3.58% | RBC Capital | $592 → $541 | Maintains | Outperform |
| 04/28/2022 | 5.51% | RBC Capital | $579 → $592 | Maintains | Outperform |
| 03/04/2022 | 3.19% | RBC Capital | $609 → $579 | Maintains | Outperform |
| 07/29/2021 | 8.54% | RBC Capital | $604 → $609 | Maintains | Outperform |
| 02/25/2021 | 3.37% | Oppenheimer | $600 → $580 | Maintains | Outperform |
| 03/11/2020 | -4.65% | RBC Capital | $448 → $535 | Upgrades | Sector Perform → Outperform |
| 02/19/2020 | -4.65% | Oppenheimer | $525 → $535 | Maintains | Outperform |
| 11/25/2019 | -16.24% | Oppenheimer | $440 → $470 | Maintains | Perform |
| 11/01/2019 | -12.67% | JMP Securities | → $490 | Upgrades | Market Perform → Market Outperform |
| 02/25/2019 | -43.33% | RBC Capital | $313 → $318 | Maintains | Sector Perform |
| 日期 | 上行/下行 | 分析公司 | 目標價格變化 | 評級變化 | 上一次/當前評級 |
|---|---|---|---|---|---|
| 2023年10月30日 | 7.65% | 加拿大皇家銀行資本 | $576→$604 | 維護 | 跑贏大盤 |
| 07/31/2023 | 2.66% | 加拿大皇家銀行資本 | $610→$576 | 維護 | 跑贏大盤 |
| 07/27/2023 | 5.15% | 奧本海默 | $610→$590 | 維護 | 跑贏大盤 |
| 05/01/2023 | 8.72% | 加拿大皇家銀行資本 | $587→$610 | 維護 | 跑贏大盤 |
| 04/28/2023 | 8.72% | 奧本海默 | $580→$610 | 維護 | 跑贏大盤 |
| 02/27/2023 | 4.62% | 加拿大皇家銀行資本 | $545→$587 | 維護 | 跑贏大盤 |
| 11/03/2022 | -2.87% | 加拿大皇家銀行資本 | $541→$545 | 維護 | 跑贏大盤 |
| 08/01/2022 | -3.58% | 加拿大皇家銀行資本 | $592→$541 | 維護 | 跑贏大盤 |
| 04/28/2022 | 5.51% | 加拿大皇家銀行資本 | $579→$592 | 維護 | 跑贏大盤 |
| 03/04/2022 | 3.19% | 加拿大皇家銀行資本 | $609→$579 | 維護 | 跑贏大盤 |
| 07/29/2021 | 8.54% | 加拿大皇家銀行資本 | $604→$609 | 維護 | 跑贏大盤 |
| 02/25/2021 | 3.37% | 奧本海默 | $600→$580 | 維護 | 跑贏大盤 |
| 03/11/2020 | -4.65% | 加拿大皇家銀行資本 | $448→$535 | 升級 | 行業表現優於→ |
| 02/19/2020 | -4.65% | 奧本海默 | $525→$535 | 維護 | 跑贏大盤 |
| 2019年11月25日 | -16.24% | 奧本海默 | $440→$470 | 維護 | 執行 |
| 2019/11/01 | -12.67% | JMP證券 | →$490 | 升級 | 市場表現優於→市場表現 |
| 2019年02月25日 | -43.33% | 加拿大皇家銀行資本 | $313→$318 | 維護 | 行業表現 |
What is the target price for Chemed (CHE)?
中國化工的目標價格是多少？
The latest price target for Chemed (NYSE: CHE) was reported by RBC Capital on October 30, 2023. The analyst firm set a price target for $604.00 expecting CHE to rise to within 12 months (a possible 7.65% upside). 7 analyst firms have reported ratings in the last year.
加拿大皇家銀行資本於2023年10月30日報道了中國化工(紐約證券交易所代碼：CHE)的最新目標價。這家分析公司將目標價定為604.00美元，預計CHE將在12個月內上漲至7.65%(可能上漲7.65%)。去年有7家分析公司公佈了評級。
What is the most recent analyst rating for Chemed (CHE)?
分析師對中國化工的最新評級是多少？
The latest analyst rating for Chemed (NYSE: CHE) was provided by RBC Capital, and Chemed maintained their outperform rating.
加拿大皇家銀行資本對中國化工(紐約證券交易所股票代碼：CHE)的最新分析師評級是由加拿大皇家銀行資本提供的，中國化工維持其表現優於大盤的評級。
When is the next analyst rating going to be posted or updated for Chemed (CHE)?
中國化工(CHE)的下一次分析師評級將於何時發佈或更新？
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Chemed, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Chemed was filed on October 30, 2023 so you should expect the next rating to be made available sometime around October 30, 2024.
分析師在進行了廣泛的研究後得出了股票評級，其中包括查閱公共財務報表，與CHIME的高管和客戶交談，以及收聽收益電話會議。大多數分析師每三個月就會這樣做一次，所以你每年應該會得到每家公司每家公司的4個評級。中國化工的上一次評級是在2023年10月30日提交的，所以你應該預計下一次評級將在2024年10月30日左右的某個時候公佈。
Is the Analyst Rating Chemed (CHE) correct?
分析師評級中國(CHE)正確嗎？
While ratings are subjective and will change, the latest Chemed (CHE) rating was a maintained with a price target of $576.00 to $604.00. The current price Chemed (CHE) is trading at is $561.10, which is out of the analyst's predicted range.
雖然評級是主觀的，並將發生變化，但最新的中國化工(CHE)評級維持不變，目標價在576.00美元至604.00美元之間。中國化工目前的交易價格為561.10美元，超出了分析師的預測範圍。